Lexaria Bioscience Corp.
LEXX
$1.35
$0.032.27%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.12M | 6.56M | 8.51M | 4.79M | 2.03M |
| Total Receivables | 263.50K | 154.50K | 208.40K | 357.10K | 534.70K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 444.10K | 1.19M | 379.50K | 266.80K | 132.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.83M | 7.90M | 9.09M | 5.42M | 2.69M |
|
|
|||||
| Total Current Assets | 8.83M | 7.90M | 9.09M | 5.42M | 2.69M |
| Net Property, Plant & Equipment | 398.60K | 389.60K | 362.60K | 376.30K | 390.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 505.40K | 516.70K | 498.90K | 519.30K | 494.40K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 64.00K | 63.60K | 63.60K | 39.50K | 48.60K |
| Total Assets | 9.79M | 8.87M | 10.02M | 6.35M | 3.63M |
|
|
|||||
| Total Accounts Payable | 262.10K | 379.90K | 121.30K | 47.70K | 92.10K |
| Total Accrued Expenses | 6.90K | 686.50K | 7.50K | 7.70K | 6.80K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 28.80K | 28.00K | 27.30K | 26.40K | 25.60K |
| Total Finance Division Other Current Liabilities | -- | 5.00K | -- | -- | -- |
| Total Other Current Liabilities | -- | 5.00K | -- | -- | -- |
| Total Current Liabilities | 297.80K | 1.10M | 156.00K | 81.70K | 124.50K |
|
|
|||||
| Total Current Liabilities | 297.80K | 1.10M | 156.00K | 81.70K | 124.50K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 101.90K | 109.30K | 115.30K | 122.50K | 129.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 399.70K | 1.21M | 271.40K | 204.20K | 254.00K |
|
|
|||||
| Common Stock & APIC | 64.06M | 59.62M | 59.52M | 54.13M | 50.68M |
| Retained Earnings | -54.26M | -51.56M | -49.37M | -47.59M | -46.94M |
| Treasury Stock & Other | -23.00K | -19.80K | -21.90K | -20.60K | 4.40K |
| Total Common Equity | 9.77M | 8.04M | 10.12M | 6.52M | 3.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.77M | 8.04M | 10.12M | 6.52M | 3.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -380.30K | -377.30K | -375.60K | -372.90K | -369.80K |
| Total Equity | 9.39M | 7.66M | 9.75M | 6.15M | 3.37M |
|
|
|||||
